Skip to content
healthcare.dev

DARIFENACIN

NDC 46708-224, DARIFENACIN, tablet, extended release, from Alembic Pharmaceuticals Limited.

Product NDC
46708-224
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207681
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-224 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARIFENACIN HYDROBROMIDE15 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
46708-224-08467080224088 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (46708-224-08)
46708-224-304670802243030 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-30)
46708-224-904670802249090 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-90)
46708-224-91467080224911000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/da7c2732-232c-4e71-92d9-577ef8617f56

Use it

Look up 46708-224 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-224 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-224. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.